EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Glycemic control and blood product quality of Canadian blood donors with diabetes

Elyn M Rowe iD, Marcus Shew, Noor Ali-Mohamad, Celina Phan, Mindy Goldman iD, Jason P Acker iD, Dana V Devine, James D Johnson iD

Transfusion · 2026-07 · 66 (7) · 1347-1357

DOI: 10.1111/trf.70223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, online erschienen am 16.04.2026. Verfasst von Elyn M Rowe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Blood Research, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Blood Donors, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Glycemic Control. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canadian Blood Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Many blood centers now accept donors with diabetes, provided their condition is “well‐controlled”. However, glycemic control is not routinely assessed at donation, and the impact of donor diabetes on blood product quality remains unclear. Study Design and Methods To screen glycemic control, glycated hemoglobin A1c (HbA1c) was measured in whole blood from 256 unique donors with either type 1 diabetes (T1D), type 2 diabetes (T2D), or without known diabetes. In parallel, routine quality control (QC) data were linked with donor metadata to assess the impact of donor diabetes on red cell concentrate (RCC) and apheresis platelet concentrate (PC) quality at the time of their expiry.

Results

Nearly half of donors with diabetes had suboptimal glycemic control (HbA1c >7 %) at donation, including 57.1 % of donors with T1D and 43.4 % with T2D. RCC units from donors with T2D ( n = 1,329) had higher hemolysis ( p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood DonorsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Glycemic ControlHumansGlycated HemoglobinFemaleMaleBlood DonationQuality ControlCanadaMiddle AgedAdultHemolysisBlood Glucose

Stichwörter der Autor:innen

HbA1cT1DT2DdiabeteshemolysispHplatelet concentratequality controlred cell concentrate

Substanzen

Glycated Hemoglobinhemoglobin A1c protein, humanBlood Glucose

Autor:innen und Institutionen

  • Centre for Blood Research, University of British Columbia, Vancouver, British Columbia, Canada.
  • Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Innovation and Portfolio Management, Canadian Blood Services, Edmonton, Alberta, Canada.
  • Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
  • Medical Affairs and Innovation, Canadian Blood Services, Ottawa, Ontario, Canada.
  • Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, British Columbia, Canada.

ORCID-Profile: Elyn M Rowe, Mindy Goldman, Jason P Acker, James D Johnson

Förderung

  • Canadian Blood Services

Zitieren

APA

Rowe, E. M., Shew, M., Ali-Mohamad, N., Phan, C., Goldman, M., Acker, J. P., Devine, D. V., & Johnson, J. D. (2026). Glycemic control and blood product quality of Canadian blood donors with diabetes. Transfusion, 66(7), 1347-1357. https://doi.org/10.1111/trf.70223

Vancouver

Rowe EM, Shew M, Ali-Mohamad N, Phan C, Goldman M, Acker JP, et al. Glycemic control and blood product quality of Canadian blood donors with diabetes. Transfusion. 2026;66(7):1347-1357. doi:10.1111/trf.70223

BibTeX
@article{Rowe2026,
  author = {Rowe, Elyn M and Shew, Marcus and Ali-Mohamad, Noor and Phan, Celina and Goldman, Mindy and Acker, Jason P and Devine, Dana V and Johnson, James D},
  title = {Glycemic control and blood product quality of Canadian blood donors with diabetes},
  journal = {Transfusion},
  year = {2026},
  volume = {66},
  number = {7},
  pages = {1347--1357},
  doi = {10.1111/trf.70223}
}
Kostenlos starten →